Molecular responses in e19a2 BCR-ABL1 chronic myeloid leukemia

• Laura Kearney,
• Mireille Crampe,
• Eibhlin Conneally,
• Janusz Krawczyk,
• Senthil Kumar,
• Philip T. Murphy,
• Vitaliy Mykytiv,
• Mary-Frances Ryan,
• Stephen E. Langabeer

Affiliations

Laura Kearney

Cancer Molecular Diagnostics, Trinity Translational Medicine Institute, St. James's Hospital, Dublin, D08 W9RT, Ireland

Mireille Crampe

Cancer Molecular Diagnostics, Trinity Translational Medicine Institute, St. James's Hospital, Dublin, D08 W9RT, Ireland

Eibhlin Conneally

Department of Haematology, St. James's Hospital, Dublin, Ireland

Janusz Krawczyk

Department of Haematology, Galway University Hospital, Galway, Ireland

Senthil Kumar

Department of Haematology, University Hospital Waterford, Waterford, Ireland

Philip T. Murphy

Department of Haematology, Beaumont Hospital, Dublin, Ireland

Vitaliy Mykytiv

Department of Haematology, Cork University Hospital, Cork, Ireland

Mary-Frances Ryan

Department of Haematology, University Hospital Limerick, Limerick, Ireland

Stephen E. Langabeer

Cancer Molecular Diagnostics, Trinity Translational Medicine Institute, St. James's Hospital, Dublin, D08 W9RT, Ireland; Corresponding author